Tag
Pharma
Live stream
RIVO news Listen to this section's headlines in an AI voice
Now:
Press play to start the stream
This browser does not support voice playback. Try Chrome, Edge or Safari.
Biotech
Rick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as…
May 30, 2026
· 1 min read
Biotech
CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.
May 30, 2026
· 1 min read
Biotech
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here. We’re ASCOmaxxing. Rest…
May 30, 2026
· 1 min read
Biotech
Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news from The Readout
May 29, 2026
· 1 min read
Biotech
Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions that support these advances, from regulators, to investors, and even public…
May 28, 2026
· 2 min read
Business
We still have a lot of questions about Trump's MFN deals with pharma companies.
May 28, 2026
· 1 min read
Biotech
Strong results from GSK's hepatitis B drug, engineered heart patches, and more biotech news from The Readout
May 28, 2026
· 1 min read
Business News
The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs will be co-preferred options
May 28, 2026
· 1 min read
Business
The public is about to get its first look at the prices of drugs launched since President Trump struck his most-favored-nation deals with 17 drugmakers.
May 28, 2026
· 1 min read
Biotech
The business of living forever, Chan Zuckerberg Biohub's AI protein model, and other biotech news from The Readout
May 27, 2026
· 2 min read
Pharma
The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel voted against the drug
May 27, 2026
· 2 min read
D.C. Diagnosis
Kyle Diamantas doesn't have the typical CV for an FDA commissioner, but he's earning early praise.
May 26, 2026
· 1 min read